Fluticasone propionate (Flonase), the corticosteroid nasal spray, is effective in controlling seasonal allergies than a combination of two popular anti-allergy drugs: loratidine (Claritin) and montelukast (Singulair). This finding was disclosed by researchers from the University of Chicago.
This study was presented on March 4 at the 58th annual meeting of the American Academy of Allergy, Asthma and Immunology.
Robert Naclerio, M.D., professor of surgery at the University of Chicago and director of the study, said that symptom scores for patients on fluticasone were better than those on a combination of two popular anti-allergy drugs.
